{"id":"W2988731068","doi":"10.1158/1078-0432.ccr-19-2078","title":"Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; National Institute on Aging; Cancer Prevention and Research Institute of Texas","keywords":"Pembrolizumab; Medicine; Oncolytic virus; Gemcitabine; Chemotherapy; Pancreatic cancer; Internal medicine; Oncology; Irinotecan; Response Evaluation Criteria in Solid Tumors; Immunotherapy; Gastroenterology; Progressive disease; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002169949,0.0001819623,0.0003352843,0.0001489786,0.0000854887,0.00004853614,0.0003832171,0.0001188266,0.00006563975],"category_scores_gemma":[0.0001191067,0.000116779,0.00003473672,0.0005602816,0.0003685639,0.00001416542,0.0001390216,0.0006991902,0.000009527736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000134413,"about_ca_system_score_gemma":0.0004820275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000291474,"about_ca_topic_score_gemma":0.005105033,"domain_scores_codex":[0.9967435,0.0009504352,0.0003513706,0.0007061556,0.0007261725,0.0005223952],"domain_scores_gemma":[0.9985819,0.0002484364,0.00007897334,0.0006689468,0.0002979812,0.0001237642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06989825,0.002787106,0.9037082,0.00002992383,0.00007747047,0.00001160985,0.0003350193,0.00005191258,0.001505544,0.000003760342,0.00005120939,0.02154003],"study_design_scores_gemma":[0.05533128,0.06690925,0.8749322,0.00006776083,0.00001087499,9.202507e-7,0.0005457512,0.0001710962,0.001479186,0.00002397749,0.0003143378,0.0002133288],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955708,0.0007756472,0.000003012172,0.0005160898,0.00002392923,0.002982323,0.000009999144,0.000005591781,0.000112593],"genre_scores_gemma":[0.9986223,0.0003937329,0.00001308203,0.0001772042,0.00004671154,0.0004670511,0.00002281483,0.00004505402,0.0002120235],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06412214,"threshold_uncertainty_score":0.4762108,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04132572632792689,"score_gpt":0.4330337923661132,"score_spread":0.3917080660381863,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}